Invokana Now Linked with Cardiovascular Injuries

Invokana is a type 2 diabetes medication that has many known dangerous side effects. There is a known link between the Janssen Pharmaceuticals Inc. drug with cardiovascular injuries and kidney failure. According to officials with the Food and Drug Administration (FDA), Invokana may also lead to decreased bone density and increased risk of bone fractures. The FDA has warned consumers of bone fracture risks when taking Invokana. But, there is new information from recent clinical trials that confirms these concerns.

As we age, our bones naturally lose density. It can be difficult to prove bone density loss resulted from taking Invokana, and not as a natural byproduct of aging. A new study of 714 elderly patients determined that patients taking Invokana had greater bone density loss than those taking a placebo. The study also found that fractures could happen early as 12 weeks after taking the dangerous prescription drug.

The FDA is now urging all doctors and health care professionals to warn patients of the many risks in taking Invokana. They even recommend weighing the risks of bone fractures before prescribing Invokana for type 2 diabetes. Doctors must also keep in mind that Invokana is one of six diabetes drugs on watch for diabetic ketoacidosis, an elevated level of blood acid.

If you’ve suffered a bone fracture or other serious side effect as a result of taking Invokana, it may be in your best interests to research you legal options. If you can show a link between your injuries and the prescription drug, you may be able to hold the manufacturer accountable for losses such as:

*Lost wages *Medical bills *Pain and suffering *Other related damages
It is possible to hold drug manufacturers accountable for the damages they cause. For more information, contact an experienced Florida pharmaceutical litigation attorney. Farah & Farah can help.

We can be reached at (800) 533-3555.

Badges